Is prothrombin complex concentrate better than fresh-frozen plasma for coagulopathy after heart surgery?

Coagulopathy means the blood's ability to clot is impaired, which can cause serious bleeding. After heart surgery, this is a known problem, and doctors often treat it with fresh-frozen plasma (FFP), a blood product that contains clotting factors. Prothrombin complex concentrate (PCC) is a different product that also contains clotting factors but in a more concentrated form. The question is whether PCC works better than FFP for this specific situation. A 2024 meta-analysis of randomized trials in cardiac surgery found that PCC reduced chest tube drainage and reoperation for bleeding compared with FFP, but the certainty of the evidence was low ¹. Other sources support PCC as an alternative to FFP in bleeding patients generally, but they do not focus on heart surgery ⁸⁹.

What the research says

A systematic review and meta-analysis of five randomized controlled trials with 711 patients undergoing cardiac surgery compared PCC with FFP for coagulopathic bleeding ¹. The PCC group had significantly less chest tube drainage (mean difference -143.59 mL, 95% CI -278.76 to -8.41 mL) and a lower rate of reoperation for bleeding (5.83% vs. 8.53%; RR 0.69, 95% CI 0.48-0.98) ¹. However, the certainty of this evidence was rated as low, meaning the true effect may be different ¹.

What to ask your doctor

• What are the benefits and risks of using prothrombin complex concentrate (PCC) versus fresh-frozen plasma (FFP) for bleeding after heart surgery in my specific case?
• How does the low certainty of the evidence affect the choice between PCC and FFP?
• Are there any situations where one option is clearly preferred over the other for me?
• What are the potential side effects or complications of each treatment?
• Could you explain how my other health conditions might influence which treatment is safer for me?